Sambrinvest

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

AdipoPharma SAS focuses on advancing treatments for insulin resistance and type 2 diabetes by harnessing the unique properties of adipocyte cells. The company develops peptide-based drugs aimed at improving insulin sensitivity and controlling blood glucose levels in patients. AdipoPharma's approach involves a comprehensive genetic analysis of conditions such as Alström syndrome and utilizes therapeutic peptides that target specific pathways to enhance lipid biosynthesis in diseased adipocytes. This targeted methodology not only addresses insulin resistance but also aims to reduce liver fibrosis and steatosis, offering low-risk treatment options for individuals managing diabetes and its associated comorbidities.

AbolerIS Pharma is a biotechnology company based in Nantes, France, focused on developing immune-modulators for the treatment of transplant rejection, graft-versus-host disease, and autoimmune diseases. Established in 2019, the company employs a unique therapeutic approach that aims to induce immune tolerance while preserving beneficial immune responses in various inflammatory and degenerative conditions. Its product portfolio includes Anti-CD45RC, a monoclonal antibody designed to deplete effector T cells, and IL-34, a cytokine that promotes the induction of tolerogenic macrophages and regulatory T cells. AbolerIS Pharma's innovative strategies enable researchers to advance novel drug development in areas with significant unmet medical needs.

Cikisi is a company that specializes in Web Intelligence, focusing on the collection, searching, and filtering of relevant online information for businesses and organizations. It develops and commercializes Cikisi WMT, a Web Intelligence Solution designed to provide real-time, tailored market insights. By leveraging artificial intelligence, the software streamlines the processes of collecting, processing, and disseminating pertinent data. This enables clients to make informed decisions more quickly, enhancing their ability to capitalize on valuable web information for their development and growth.

Santero Therapeutics is focused on developing innovative antibiotics aimed at addressing the challenges posed by multi-drug-resistant pathogens. The company creates medications that employ novel mechanisms of action to effectively combat infections resistant to traditional treatments. By providing therapies that maintain prolonged efficacy, Santero aims to improve patient outcomes and offer better-tolerated options for those afflicted with difficult-to-treat infections. Through its research and development efforts, Santero Therapeutics seeks to contribute to the fight against antibiotic resistance, a growing concern in modern medicine.

Sunrise focuses on addressing the widespread issue of sleep disorders, particularly sleep apnea, which affects nearly one billion people globally. The company has developed a 3-gram sensor that provides a rapid, at-home diagnosis of sleep apnea, utilizing trigeminal drive analysis to detect respiratory events. This certified medical device connects seamlessly to a smartphone, allowing for easy use and immediate results. Clinical studies have demonstrated that Sunrise's technology matches the accuracy of traditional in-lab sleep studies but at a significantly lower cost. After testing, patients can consult with certified sleep doctors online or visit local sleep centers, streamlining the diagnostic process. With a large percentage of sleep apnea cases remaining undiagnosed, Sunrise offers a crucial solution for patients, caregivers, and insurers, enhancing the accessibility and efficiency of sleep disorder diagnostics.

Exthand specializes in open banking solutions that enable clients to connect to the APIs of 95% of banks across Europe, the UK, and Israel through a single interface. This connectivity facilitates instant account-to-account payments and the retrieval of financial data, making transactions faster and more cost-effective. The company's services support a range of applications, including personal finance management, credit scoring, cash flow management, and enhancements to e-commerce and marketplace platforms. By streamlining access to banking information, Exthand aims to improve financial processes for businesses and consumers alike.

Aerospacelab SA, founded in 2017 and headquartered in Mont-Saint-Guibert, Belgium, specializes in the development and manufacturing of small satellites equipped with advanced sensors. The company focuses on addressing complex challenges through innovative solutions, including the use of artificial intelligence and machine learning to automate various tasks. Aerospacelab's technology enables the collection of high-resolution optical data and provides a platform that facilitates the analysis of large datasets. This capability allows customers to effectively survey and monitor diverse applications, optimizing the transformation of the information gathered.

Cake App mission is to become the leading software technology provider that analyzes financial data to help people better understand, control and improve their finances, supported by a business model that shares our revenue with users.

HeartKinetics focuses on developing artificial intelligence solutions for the rapid and precise detection of heart failure and cardio-toxicity. Utilizing a network of nine AI models trained on extensive patient data from the Mayo Clinic Platform, the company tests cardiac mechanical and electrical functions to identify issues such as ventricular ejection dysfunction and arrhythmias within minutes. Their innovative approach includes a lightweight solution that incorporates motion sensors in Holter ECG patches, aiming to predict cardiac complications and facilitate timely therapeutic decisions. Additionally, HeartKinetics offers a cloud-based healthcare application that transforms data into actionable insights, empowering healthcare professionals to tailor treatments to individual patient needs.

PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

HireRing is an on-demand staffing platform that connects employers with specialized recruitment agencies tailored to meet specific hiring needs. The platform streamlines the process, allowing employers to quickly submit vacancy requests and set their desired hiring fees upfront. This efficient marketplace enables recruitment agencies to select suitable business opportunities, ensuring that both employers and recruiters can engage effectively. As a result, HireRing facilitates a seamless hiring experience, enhancing the quality of recruitment services delivered to employers.

EsoBiotec is a Belgian biotechnology company dedicated to the discovery and development of novel cancer therapies. The firm focuses on empowering the human body to combat cancer through in vivo cell engineering. By creating innovative immunotherapies, EsoBiotec aims to provide cost-effective drugs and therapeutics that enhance accessibility, ensuring that patients can receive essential cancer treatments at lower costs.

Sortlist is an online platform designed to assist businesses in finding marketing and communication agencies that meet their specific needs. By utilizing a multi-criteria searching tool, Sortlist connects marketing managers with suitable partners quickly and efficiently, allowing them to focus on their core objectives. The platform is linked to professional networks and incorporates peer-to-peer recommendations, making the search process more effective for businesses of all sizes and sectors. With Sortlist, clients can streamline their search for service providers, ensuring they find the right match to achieve their marketing and communication goals.

Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β (Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.

Shyfter is a scheduling platform designed to enhance workforce management across various industries. It enables the creation and adjustment of employee schedules, leveraging AI to optimize staffing and productivity. The platform includes real-time time tracking, absence management, and communication channels for effective team coordination. Managers can quickly respond to staffing changes, approve leave requests, and ensure compliance with labor regulations, significantly reducing administrative tasks and minimizing scheduling conflicts. Shyfter also provides advanced analytics that deliver insights into workforce trends, aiding businesses in making informed decisions to improve operational efficiency and employee satisfaction. Tailored for small to medium-sized enterprises, Shyfter is customizable to fit specific organizational needs, making it a valuable tool for efficient workforce management.

ExeVir Bio BV, founded in 2020 and based in Zwijnaarde, Belgium, specializes in developing single-domain antibody-based therapies aimed at combating viral infections. The company leverages a llama-derived antibody technology platform to create robust antiviral treatments that offer broad protection against coronaviruses. Notably, it is developing VHH72-FC, an antibody that targets a highly conserved region on the spikes of SARS-CoV-2, crucial for the virus's entry into human cells. ExeVir Bio's rapid response platform for antivirals allows for an agile approach to emerging health threats, enabling the swift generation of drug candidates. The therapeutics produced through this innovative technology are designed to be stable, cost-effective, and accessible on a global scale.

OncoDNA is a theranostic and genomic company that specializes in precision medicine for cancer and genetic diseases. Founded by a team with over 60 years of experience in medical diagnostics, the company focuses on providing clinical guidance for the treatment and real-time monitoring of late-stage cancer patients. OncoDNA supports researchers and biopharma companies in navigating the complexities of molecular biology, facilitating research and drug development in oncology. With its commitment to delivering precision medicine, OncoDNA aims to enhance treatment outcomes and improve the management of cancer and genetic disorders.

PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

Utopix Pictures SA is a Belgium-based company founded in 2015 that operates a platform designed to connect users with professionals in the photography, film, and imaging sectors. The company aims to simplify the process of finding the right photographer or videographer to meet specific project needs. By leveraging a network of skilled professionals, Utopix Pictures assists clients in transforming their ideas into compelling visual content efficiently and effectively.

Cognivia specializes in creating analytical tools that enhance and expedite the clinical development of new medicines. The company focuses on developing predictive techniques that improve the clinical evaluation of drugs and other therapeutics. By addressing key sources of variability in clinical trial data, Cognivia enables clients to better identify and manage challenges, ultimately leading to more efficient and effective clinical trials.

Smartbeam is a construction technology platform that facilitates connections among stakeholders in real estate construction projects while enhancing financial monitoring at construction sites. The platform offers features such as automated data collection and analysis, as well as real-time budget tracking, which aids in efficient budget management. By supporting collaboration from the pre-construction phase through to the construction phase, Smartbeam enables construction professionals to streamline workflows, reduce rework, and increase productivity. The platform is designed to enhance budget reliability and minimize financial risks, ultimately improving project efficiency and collaboration.

Djengo specializes in smart parking management and green mobility software designed for companies. Their flagship product, Commuty, optimizes the use of corporate parking and office space through an automated reservation system. The platform manages various parking needs, including those for visitors, individuals with reduced mobility, carpoolers, and bicycles, as well as electric vehicle chargers. Additionally, Djengo offers a ridesharing facility that facilitates home-to-work commuting by providing an online and mobile platform for peer-to-peer ridesharing and carpooling, enhancing the efficiency of transportation solutions for businesses and their employees.

With Commuty, they save money while reducing constraints and increasing flexibility. Smart parking management organises company managed parking spots allocationsand bookings according to their parking policy. Bicycle raising connects cyclers with similar routes, organises the use of shared bicycles and automates kilometer refund. Ride sharing elevation connects riders, automates ride sharing tax advantage and organises guaranteed return.

Sortlist is an online platform designed to assist businesses in finding marketing and communication agencies that meet their specific needs. By utilizing a multi-criteria searching tool, Sortlist connects marketing managers with suitable partners quickly and efficiently, allowing them to focus on their core objectives. The platform is linked to professional networks and incorporates peer-to-peer recommendations, making the search process more effective for businesses of all sizes and sectors. With Sortlist, clients can streamline their search for service providers, ensuring they find the right match to achieve their marketing and communication goals.

Minoryx, they are committed to finding innovative treatments for life threatening rare diseases. They focus on pediatric diseases and they are currently working on treatments for neurometabolic diseases of genetic origin.Minoryx develops a new generation of small molecule drugs known as pharmacological chaperones, which offer the most promising approach to the treatment of genetic diseases severely affecting the central nervous system. As a complementary approach, Minoryx is also involved in repositioning-based projects.

ChromaCure is engaged in the development of innovative cancer therapies, focusing on discovering first-in-class small molecule therapeutics to address unmet needs in oncology. The company is initiating a drug development program aimed at identifying new candidates that selectively and potently inhibit cancer targets. This initiative seeks to provide novel treatment options for multiple forms of cancer, either as standalone therapies or in combination with existing immunotherapy or chemotherapy approaches. Through its efforts, ChromaCure aims to enhance the therapeutic landscape for cancer patients, offering potential new solutions for various cancer types.

Ncardia is a biotechnology company focused on expediting the drug discovery and development process. The company leverages human induced pluripotent stem cell (hiPSC) technology to create predictive human cellular assay systems, which are used for safety and efficacy testing of drug candidates. Additionally, Ncardia enhances cardiovascular and neural drug screening, providing researchers and drug discovery companies with tools to better understand human disease biology. This approach aims to accelerate the overall drug discovery process, facilitating the development of safer and more effective therapeutic options.

Ncardia is a biotechnology company focused on expediting the drug discovery and development process. The company leverages human induced pluripotent stem cell (hiPSC) technology to create predictive human cellular assay systems, which are used for safety and efficacy testing of drug candidates. Additionally, Ncardia enhances cardiovascular and neural drug screening, providing researchers and drug discovery companies with tools to better understand human disease biology. This approach aims to accelerate the overall drug discovery process, facilitating the development of safer and more effective therapeutic options.

Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).

X4C specializes in developing advanced molecular coatings for life science applications, focusing on in vitro diagnostics. The company utilizes innovative monolayer chemical coating technology to create robust organic monolayers that can be easily modified, allowing for enhanced functionality of various substrates. Their product offerings include nanoparticles and calixarenes, along with custom services tailored to meet specific industry needs. X4C's coatings are designed for a range of applications, including diagnostics, medical devices, electronics, and optics, ensuring that healthcare professionals can maintain the inherent properties of materials while enhancing their performance.

Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).

Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).

Calyos is a company that specializes in thermal regulation systems, particularly focusing on advanced loop heat pipe cooling products. Originating from the space industry, Calyos leverages its extensive expertise and scalable manufacturing capabilities alongside patented technologies. The company's innovative systems utilize a dielectric fluid that effectively absorbs heat and boils at low temperatures, providing efficient cooling solutions for high-performance electronics. These products are applicable across various sectors, including servers, renewable energy systems, and telecommunication equipment. By eliminating thermal limitations, Calyos empowers clients to design competitive and reliable electronic products.